Market Overview

Benzinga's Top #PreMarket Losers

Related MYL
Wall Street's M&A Chatter From January 19
The Difference Between Mylan's EpiPen And Generic Offerings
Related TEVA
Benzinga's Top Upgrades, Downgrades For January 20, 2017
The Market In 5 Minutes: Trump Inauguration Takes Center Stage
Drug Stocks: Great Buys Or Value Traps? (Seeking Alpha)

Mylan NV (NASDAQ: MYL) shares declined 13.92 percent to $56.76 in pre-market trading. Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) announced its plans to buy Allergan PLC's (NYSE: AGN) generic drugs unit for $40.5 billion in a cash and stock deal. Teva also reported that it has dropped its $40 billion cash and stock bid for Mylan.

China Information Technology, Inc. - Ordinary Shares (NASDAQ: CNIT) shares dropped 9.09 percent to $2.30 in pre-market after declining 1.94 percent on Friday.

Weibo Corp (ADR) (NASDAQ: WB) shares tumbled 8.43 percent to $13.26 in pre-market trading after falling 2.95 percent on Friday.

JD.Com Inc(ADR) (NASDAQ: JD) fell 5.95 percent to $32.58 in pre-market trading after slipping 0.17 percent on Friday. Inc (NASDAQ: SOHU) shares fell 5.89 percent to $42.05 in pre-market trading after dropping 3.29 percent on Friday.

Posted-In: PreMarket LosersNews Movers & Shakers Pre-Market Outlook Markets


Related Articles (AGN + CNIT)

View Comments and Join the Discussion!